Navigation Links
Pilling-Weck Medium Clip (insert only)

ProductsPilling-Weck Medium Clip (insert only)
Company SOLOS Endoscopy, Inc.
Item Pilling-Weck Medium Clip (insert only)
Features 
  • Clip applying forceps
  • Pilling-Weck
  • Medium clip size
  • Insert only
  • Description Insert only, Pilling-Weck medium clip size
    Info SOLOS Endoscopy, Inc.
    Customer Service: (800) 388-6445
    Web site: http://www.solosendoscopy.com

    Related medicine products :

    1. Pilling-Weck Small Clip
    2. Pilling-Weck Medium-Large Clip (insert only)
    3. Pilling-Weck Small Clip (insert only)
    4. Pilling-Weck Medium Clip
    5. Pilling-Weck Medium-Large Clip
    6. Wilder Lacrimal Dilator - Medium
    7. Symblepharon Ring - Medium
    8. Cougar Medium Footprint
    9. Medium Ocelot Stackable Cage System
    10. The Natural-Hip Family - Medium Demand Premier
    11. Medium External Fixator
    This device is a qualitative immunoassay intended to be used to inspect the,overdose usage of cocaine by detecting the benzoylecgonine, a metabolite of,cocaine, in human urine at a cutoff level of 30
    The RapidBZO test is an immunochromatography based one step in vitro test. It is,designed for qualitative determination of Benzodiazepines and their metabolites in human,urine specimens above a cut-o
    ...ied Biosystems introduced the completely automated...,Now the innovative technology of the 3100 instr...RISM 3100-Avant Genetic,Analyzer. Designed for l...ly automated 3100-Avant system can analyze,hundr...
    AcT diff2 delivers performance, value and safety for physician office labs and smaller laboratories. It's an affordable, easy-to-use system that offers a small sample volume in both open and closed a
    Medicine Products:
    (Date:8/21/2008)... New names and fresh websit... UME/GME administration software , ... one45 Software, a leading provider of healthcare ... of Cytiva Software Inc. (CRX:TSX.V), announced to...hcare education administration products., , ,Compl...
    (Date:8/20/2008)... NEWTON, Mass., Aug. 20 /PRNewswire/ -- Questex M...o-business media company and owner of,American Spa... and the,International Beauty Shows, the Internati...) and the SPATEC appointment events today announce...stry portals SpaTrade (, http://www.SpaTrade.com ...
    (Date:8/20/2008)... Survey Report Is Available at http://ww...Newswire/ -- A new survey released today,documents...re leveraging,health information technology (HIT) ...The survey results highlight the need for many HIT...dization and,interoperability to optimize clinical...
    (Date:8/20/2008)...use postponed reproductive onset in teen, adult fe...EDNESDAY, Aug. 20 (HealthDay News) -- Alcoholism i...ccording to a study that compared women,s and men,... age when they had their first child. , The re...ian twins born between 1893-1964 (3,634 female and...
    Breaking Medicine News(10 mins):Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 2Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 3Health News:Cytiva's one45 Software Rebrands Healthcare Education Administration Products 4Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 2Health News:Questex Acquires Leading Spa Industry Portal and Spa Executive Business Networking Site and Events 3Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 2Health News:New Health IT Survey for Care Management Services Shows Opportunities for Integration, Standardization and Innovation 3Health News:Women's Alcohol Use Tied to Delayed Childbearing 2
    ... great lengths to hide their pregnancies or even c...ing birth may not be getting// the psychiatric car...study of more than 30,000 birth records at a Midwe...iedman, M.D., of Case Western Reserve University, ...
    ...o devote more time to physical activity have a red... next 15 years, according to new research// . “T...sical activity is actually causally related to hyp...or David Jacobs, Jr., Ph.D. Jacobs, an epidemiolo...
    ...tion in non-obese people too is not without benefi...ge in muscle cells which delays// aging and extend...ony Civitarese, Eric Ravussin, and colleagues (Pen...xidative damage has been linked to aging, and this...
    ...conducted on mice shows that more copper in everyd...s conducted by scientists at the University of Lou...ion Research Center. Their studies show that givi...he stress on their over-worked hearts by preventin...
    Other Medicine News:Health News:Women Who Deny or Hide Pregnancies Get Little Psychiatric Care 2Health News:Physical Activity Reduces Hypertension Risk in Young Adults 2Health News:Caloric Restriction in Non-obese People Extends Life Span 2
    (Date:8/20/2008)... MONTREAL, Aug. 20 /- Enobia Pha...ping novel therapeutics for serious bone,disorders...inical program,for hypophosphatasia has been dosed...py (ERT) with ENB-0040 for the treatment of this r...which there is no approved,treatment., Under two ...
    (Date:8/20/2008)... WOBURN, Mass., Aug. 20 /- BioVe... stage treatments for cancer and the prevention,of...nes and Healthcare,products Regulatory Agency (MHR...n to conduct a Phase I clinical study testing the ...isease candidate for genital herpes,ImmunoVEX HSV...
    (Date:8/19/2008)... BETHLEHEM, Pa., Aug. 19 /- Part...oduct (drug-eluting polymers) development and,pilo... a compounding,extrusion and injection molding li... twin-screw compounding extruder and Nissei 20T in...lity drug loaded polymeric,devices. This addition ...
    (Date:8/19/2008)... NEW HAVEN, Conn., Aug. 19 /PRNewswire-FirstC...ION) announced today that it had,entered into an a...Group,for Hematology Oncology (the "HOVON") to con...R) (VNP40101M)) with standard remission-induction,...reated acute myelogenous,leukemia (AML) and high-r...
    Breaking Medicine Technology:Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 2Enobia Pharma Initiates Clinical Testing of Enzyme Replacement Therapy to Treat Hypophosphatasia 3BioVex Announces Regulatory Clearance to Commence a Clinical Study With ImmunoVEX HSV2; A Vaccine Candidate for Genital Herpes 2Particle Sciences Expands Its Combination Product Capabilities 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 2Vion Pharmaceuticals Enters Into Agreement With HOVON to Conduct a Phase III Clinical Trial of Cloretazine(R) in Combination With Frontline AML and MDS Therapy 3Epsilon Securities LLC to Provide M 26A Advisory Services to MEDdevice Acquisition Co LLC 18774 1Reaching a Milestone 3A Project Smile Makes Local Charities and Patients Smile 18770 1Siemens and LabCorp Enter Agreement to Co Develop New Clinical Diagnostic Tests 2013 1Siemens and LabCorp Enter Agreement to Co Develop New Clinical Diagnostic Tests 2013 2Siemens and LabCorp Enter Agreement to Co Develop New Clinical Diagnostic Tests 2013 3Siemens and LabCorp Enter Agreement to Co Develop New Clinical Diagnostic Tests 2013 4Depression diversity 3A Brain studies reveal big differences among individuals 18765 1Depression diversity 3A Brain studies reveal big differences among individuals 18765 2Depression diversity 3A Brain studies reveal big differences among individuals 18765 3
    ...icians should find these data reassuring", PHILADE...xoSmithKline said today that findings from an inte...r Cardiac Outcomes and,Regulation of glycemia in D...ecifically to determine cardiovascular outcomes in...ds further evidence to,the overall cardiovascular ...
    ...SS WIRE)--Jun 6, 2007 - Metabasis Therapeutics,In...sed on the,discovery, development and commercializ...c and liver diseases by applying unique,capabiliti...ounced,today that two posters were presented at th...to, Canada., Both posters provide data on MB07811,...
    Other Medicine Technology:Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 2Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 3Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 4Interim Data From RECORD Study Show No Significant Difference,Between Avandia and Standard Therapy in Risk of Cardiovascular,Hospitalization or Death 5Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 2Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 3Metabasis Therapeutics Presents Results of Preclinical Studies for,MB07811, Its Novel Product Candidate for the Treatment of,Hyperlipidemia, at the Endocrine Society's Annual Meeting 4